Rhaeos is a VC backed, clinical stage medical device company developing FlowSense, a platform technology and a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow peripherally throughout the body. The company is initially targeting hydrocephalus, a life threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF). Implantable shunts, the gold standard treatment, often fail, leading to multiple trips to the emergency room and repeat surgeries. There is no technology available today that can easily assess CSF flow in shunts wirelessly, bedside, and without capital equipment until now.
FlowSense, is a proprietary wireless, wearable, and noninvasive sensor that can be mounted on skin overlying the shunt to detect the presence and magnitude of CSF. Its miniaturized, thin construction is similar in size to a bandage, and it is composed primarily of soft, silicone rubber with no hard edges. Data is wirelessly transmitted to a custom designed mobile app.
Rhaeos received FDA breakthrough designation for FlowSense, is NIH and NSF funded (>$5M), published clinical data in Science and Nature family journals, and is on track for initial market entry in 2022. Follow on products for other chronic conditions are currently in development.
Come join us, we're hiring!
FlowSense, is a proprietary wireless, wearable, and noninvasive sensor that can be mounted on skin overlying the shunt to detect the presence and magnitude of CSF. Its miniaturized, thin construction is similar in size to a bandage, and it is composed primarily of soft, silicone rubber with no hard edges. Data is wirelessly transmitted to a custom designed mobile app.
Rhaeos received FDA breakthrough designation for FlowSense, is NIH and NSF funded (>$5M), published clinical data in Science and Nature family journals, and is on track for initial market entry in 2022. Follow on products for other chronic conditions are currently in development.
Come join us, we're hiring!
Location: United States, Illinois, Evanston
Employees: 11-50
Total raised: $12.7M
Founded date: 2018
Investors 5
| Date | Name | Website |
| - | SWPDC | swpdc.org/ |
| - | KidsX | kidsx.heal... |
| 09.11.2021 | Creative V... | creativeve... |
| 28.12.2021 | Band of An... | bandangels... |
| - | K2X | k2x.capita... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.02.2023 | Series A | $10.5M | - |
| 06.01.2022 | Seed | $2.2M | - |
Mentions in press and media 12
| Date | Title | Description |
| 20.02.2023 | Illinois-based medical technology startup Rhaeos raises USD 10.5 million in Series A funding | EVANSTON, IL, February 16, 2023, To address an unmet need in the treatment of people with hydrocephalus, Rhaeos®, Inc. (Rhaeos), a clinical-stage medical device company, announced the successful closing of USD 10.5 million in Series A fundi... |
| 17.02.2023 | Rhaeos Raises $10.5M in Series A Funding | Rhaeos, a Evanston, IL-based clinical stage medical device company, raised $10.5M in Series A funding. The round was led by Steele Foundation for Hope with participation from Creative Ventures and Lateral Capital. The company intends to use... |
| 03.01.2022 | Rhaeos Raises $2.2M in Seed Funding | Rhaeos, Inc., a Evanston, Ill.-based clinical stage medical device company developing a platform wireless and non-invasive wearable sensor initially targeting the neurosurgical suite, closed a $2.2m seed financing. The round, which brings a... |
| 28.12.2021 | Rhaeos Pulls In $2.2M Seed Financing | EVANSTON, IL, Rhaeos has announced the successful closing of its oversubscribed $2.2 million seed financing. >> Click here for more funding data on Rhaeos >> To export Rhaeos funding data to PDF and Excel, click here Rhae... |
| 24.12.2021 | Rhaeos, Inc. announced that it has received $2.2 million in funding from a group of investors | Rhaeos, Inc. announced that it has received $2,200,000 in a round of funding on December 24, 2021. The transaction included participation from new investors Creative Ventures, Inc., Lateral Capital LLC, The Cedars-Sinai Accelerator, Kyto Te... |
| 27.09.2021 | Cedars-Sinai Accelerator selects 8 new health tech startups | The Cedars-Sinai Accelerator has selected eight health technology startups to participate in its seventh class. As part of the accelerator, the companies’ leaders will get the opportunity to work closely with doctors, researchers and admini... |
| 06.10.2020 | Rhaeos and its shunt monitor win MedTech Innovator’s 2020 global competition | The Flowsense shunt monitor [Image courtesy of Rhaeos]MedTech Innovator announced today that wearable head shunt monitor startup Rhaeos has won its 2020 Global Competition. Rhaeos (Evanston, Ill.) won the competition and $350,000 grand priz... |
| 06.04.2020 | TMCx names 9 health tech startups to its 2020 cohort | Now, more than ever, is time to think about the future of health care. Lucky for the Texas Medical Center, they've been doing that for years with their accelerator program, TMCx, which has just announced its latest cohort of health tech sta... |
| 04.02.2020 | TMCx names 19 startups to be considered for 2020 cohort | The Texas Medical Center is one step closer to narrowing down its next TMCx cohort. It will be the first group of startups for the accelerator following an overhaul and redesign of the program that was announced last year. TMCx has identifi... |
| - | Rhaeos | “Rhaeos – Wearable Devices” |
Show more